title: Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists.
abstract: The formyl peptide receptor 2 (FPR2) is a remarkably versatile transmembrane protein belonging to the G-protein coupled receptor (GPCR) family. FPR2 is activated by an array of ligands, which include structurally unrelated lipids and peptide/proteins agonists, resulting in different intracellular responses in a ligand-specific fashion. In addition to the anti-inflammatory lipid, lipoxin A4, several other endogenous agonists also bind FPR2, including serum amyloid A, glucocorticoid-induced annexin 1, urokinase and its receptor, suggesting that the activation of FPR2 may result in potent pro- or anti-inflammatory responses. Other endogenous ligands, also present in biological samples, include resolvins, amyloidogenic proteins, such as beta amyloid (Aβ)-42 and prion protein (Prp)106-126, the neuroprotective peptide, humanin, antibacterial peptides, annexin 1-derived peptides, chemokine variants, the neuropeptides, vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP)-27, and mitochondrial peptides. Upon activation, intracellular domains of FPR2 mediate signaling to G-proteins, which trigger several agonist-dependent signal transduction pathways, including activation of phospholipase C (PLC), protein kinase C (PKC) isoforms, the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, the mitogen-activated protein kinase (MAPK) pathway, p38MAPK, as well as the phosphorylation of cytosolic tyrosine kinases, tyrosine kinase receptor transactivation, phosphorylation and nuclear translocation of regulatory transcriptional factors, release of calcium and production of oxidants. FPR2 is an attractive therapeutic target, because of its involvement in a range of normal physiological processes and pathological diseases. Here, we review and discuss the most significant findings on the intracellular pathways and on the cross-communication between FPR2 and tyrosine kinase receptors triggered by different FPR2 agonists.
authors.affiliation: Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy. rosario.ammendola@unina.it.
authors.forename: Fabio
authors.initials: F
authors.lastname: Cattaneo
authors.forename: Melania
authors.initials: M
authors.lastname: Parisi
authors.forename: Rosario
authors.initials: R
authors.lastname: Ammendola
mesh_terms: D000818:Animals; D001419:Bacteria / Q000378:metabolism; D006801:Humans; D008024:Ligands; D019151:Peptide Library; D010455:Peptides / Q000494:pharmacology; D044042:Receptors, Formyl Peptide / Q000819:agonists* / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D008024:Ligands; D019151:Peptide Library; D010455:Peptides; D044042:Receptors, Formyl Peptide
references.citation: Bioorg Med Chem Lett. 2006 Jul 15;16(14):3713-8
references.pmid: 16697190
references.citation: J Immunol. 2009 Nov 1;183(9):5511-7
references.pmid: 19843937
references.citation: J Immunol. 2009 Sep 15;183(6):3761-9
references.pmid: 19692643
references.citation: J Immunol. 2010 Oct 1;185(7):4302-10
references.pmid: 20817875
references.citation: Exp Mol Med. 2012 Feb 29;44(2):130-7
references.pmid: 22089089
references.citation: J Immunol. 2008 Jul 1;181(1):22-6
references.pmid: 18566366
references.citation: Mol Pharmacol. 2010 Feb;77(2):159-70
references.pmid: 19903830
references.citation: Cell Calcium. 2008 Mar;43(3):270-84
references.pmid: 17651798
references.citation: Biochem Biophys Res Commun. 1992 Apr 30;184(2):582-9
references.pmid: 1374236
references.citation: J Biol Chem. 2001 Jun 15;276(24):21585-93
references.pmid: 11285256
references.citation: J Immunol. 1999 May 15;162(10):5924-30
references.pmid: 10229829
references.citation: Cell Calcium. 2009 May;45(5):431-8
references.pmid: 19282028
references.citation: Free Radic Biol Med. 2004 Jan 15;36(2):189-200
references.pmid: 14744631
references.citation: Mol Cancer Ther. 2007 Oct;6(10):2618-25
references.pmid: 17938258
references.citation: Am J Physiol Cell Physiol. 2003 Apr;284(4):C888-96
references.pmid: 12456400
references.citation: Biochemistry. 1995 Dec 26;34(51):16678-86
references.pmid: 8527441
references.citation: J Immunol. 1999 Dec 15;163(12):6777-84
references.pmid: 10586077
references.citation: J Immunol. 2006 Oct 15;177(8):5585-94
references.pmid: 17015746
references.citation: Blood. 2003 Feb 15;101(4):1572-81
references.pmid: 12393391
references.citation: J Exp Med. 2004 Jul 5;200(1):69-78
references.pmid: 15238606
references.citation: Chem Rev. 2011 Oct 12;111(10):5922-43
references.pmid: 21766791
references.citation: Acta Pharmacol Sin. 2011 May;32(5):601-10
references.pmid: 21499285
references.citation: Pharmacol Rev. 2004 Jun;56(2):249-90
references.pmid: 15169929
references.citation: Oncogene. 2011 Sep 8;30(36):3887-99
references.pmid: 21499310
references.citation: Prog Lipid Res. 2011 Jan;50(1):75-88
references.pmid: 20887750
references.citation: J Exp Med. 1994 Jul 1;180(1):253-60
references.pmid: 8006586
references.citation: J Immunol. 2004 Aug 15;173(4):2652-9
references.pmid: 15294982
references.citation: Arch Biochem Biophys. 2007 Mar 15;459(2):288-94
references.pmid: 17166481
references.citation: Clin Immunol. 2001 Jun;99(3):365-72
references.pmid: 11358433
references.citation: FEBS Lett. 2008 Mar 5;582(5):579-85
references.pmid: 18243142
references.citation: FEBS J. 2005 Feb;272(3):769-78
references.pmid: 15670157
references.citation: J Neurosci Methods. 2009 Jun 30;181(1):1-5
references.pmid: 19447501
references.citation: J Biol Chem. 2005 Jul 1;280(26):25225-32
references.pmid: 15866865
references.citation: Mol Biol Cell. 2006 Jan;17(1):367-78
references.pmid: 16267271
references.citation: Blood. 2006 Mar 1;107(5):2123-30
references.pmid: 16278303
references.citation: J Biol Chem. 2006 Jul 14;281(28):19588-99
references.pmid: 16675446
references.citation: J Leukoc Biol. 2008 Apr;83(4):972-81
references.pmid: 18174366
references.citation: Eur J Immunol. 2007 Jul;37(7):1966-77
references.pmid: 17559171
references.citation: J Clin Invest. 2001 Oct;108(8):1221-8
references.pmid: 11602630
references.citation: Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):935-40
references.pmid: 22215599
references.citation: Regul Pept. 1998 Jan 2;73(1):1-33
references.pmid: 9537670
references.citation: Br J Pharmacol. 2004 Jan;141(1):37-46
references.pmid: 14662730
references.citation: J Cell Biochem. 2011 Aug;112(8):2097-105
references.pmid: 21465531
references.citation: J Biol Chem. 1992 Apr 15;267(11):7637-43
references.pmid: 1373134
references.citation: Pharmacol Rev. 2000 Jun;52(2):269-324
references.pmid: 10835102
references.citation: Am J Physiol Cell Physiol. 2005 Sep;289(3):C557-63
references.pmid: 15901601
references.citation: Biochem Biophys Res Commun. 2004 Nov 5;324(1):255-61
references.pmid: 15465011
references.citation: Blood. 2001 May 15;97(10):2941-7
references.pmid: 11342415
references.citation: J Neurochem. 2010 May;113(3):749-60
references.pmid: 20141570
references.citation: FASEB J. 2011 May;25(5):1697-705
references.pmid: 21307335
references.citation: Am J Pathol. 2004 Mar;164(3):937-46
references.pmid: 14982847
references.citation: FASEB J. 2011 Feb;25(2):483-96
references.pmid: 20930115
references.citation: Exp Mol Med. 2009 May 31;41(5):325-33
references.pmid: 19307752
references.citation: Blood. 2000 Mar 1;95(5):1810-8
references.pmid: 10688842
references.citation: J Biol Chem. 1996 Apr 5;271(14):8170-5
references.pmid: 8626507
references.citation: Prostaglandins Leukot Essent Fatty Acids. 2005 Sep-Oct;73(3-4):189-96
references.pmid: 16125377
references.citation: Blood. 2003 May 15;101(10):4140-7
references.pmid: 12560218
references.citation: J Neurochem. 2007 May;101(3):718-28
references.pmid: 17448144
references.citation: Cell Signal. 2007 Oct;19(10):2106-17
references.pmid: 17643960
references.citation: J Immunol. 2006 Mar 1;176(5):2969-75
references.pmid: 16493055
references.citation: J Immunol. 2007 Dec 15;179(12):8533-43
references.pmid: 18056401
references.citation: Arthritis Rheum. 2004 Jun;50(6):1788-99
references.pmid: 15188355
references.citation: Mol Pharmacol. 2003 Sep;64(3):721-30
references.pmid: 12920210
references.citation: Life Sci. 2004 Sep 17;75(18):2217-32
references.pmid: 15325847
references.citation: Mucosal Immunol. 2013 Mar;6(2):256-66
references.pmid: 22785226
references.citation: J Immunol. 2000 Aug 1;165(3):1573-81
references.pmid: 10903766
references.citation: Mol Cancer Res. 2009 Feb;7(2):266-74
references.pmid: 19208747
references.citation: J Leukoc Biol. 1999 Feb;65(2):241-8
references.pmid: 10088607
references.citation: Infect Immun. 2012 Jun;80(6):1987-95
references.pmid: 22431645
references.citation: J Exp Med. 1999 Jan 18;189(2):395-402
references.pmid: 9892621
references.citation: J Biol Chem. 2000 Sep 8;275(36):27566-75
references.pmid: 10869343
references.citation: J Exp Med. 2000 Apr 3;191(7):1197-208
references.pmid: 10748237
references.citation: J Neurochem. 2007 Nov;103(4):1553-66
references.pmid: 17727628
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3806-11
references.pmid: 19234121
references.citation: J Exp Med. 2008 May 12;205(5):1077-86
references.pmid: 18411340
references.citation: J Biol Chem. 2012 Dec 21;287(52):43730-40
references.pmid: 23118226
references.citation: Free Radic Biol Med. 2011 Sep 15;51(6):1126-36
references.pmid: 21708247
references.citation: J Med Chem. 2009 Aug 27;52(16):5044-57
references.pmid: 19639995
references.citation: Proc Natl Acad Sci U S A. 2001 May 22;98(11):6336-41
references.pmid: 11371646
references.citation: Eur J Immunol. 2005 Aug;35(8):2486-95
references.pmid: 16025565
references.citation: J Exp Med. 2000 Oct 2;192(7):1069-74
references.pmid: 11015447
references.citation: J Immunol. 2004 Nov 1;173(9):5739-48
references.pmid: 15494526
references.citation: Neurochem Res. 2010 Dec;35(12):2018-26
references.pmid: 21042851
references.citation: Mol Cancer Res. 2009 Jun;7(6):907-15
references.pmid: 19491199
references.citation: Am J Respir Cell Mol Biol. 2006 Jan;34(1):65-72
references.pmid: 16141446
references.citation: Arch Biochem Biophys. 2009 Jan 1;481(1):94-100
references.pmid: 18996352
references.citation: Cell Host Microbe. 2010 Jun 25;7(6):463-73
references.pmid: 20542250
references.citation: J Biol Chem. 2012 Jul 13;287(29):24690-7
references.pmid: 22610094
references.citation: J Clin Invest. 2003 Jun;111(11):1665-72
references.pmid: 12782669
references.citation: J Immunol. 2004 Jun 15;172(12):7669-76
references.pmid: 15187149
references.citation: Biochem Biophys Res Commun. 2005 May 13;330(3):989-98
references.pmid: 15809093
references.citation: J Leukoc Biol. 2008 May;83(5):1174-80
references.pmid: 18252871
references.citation: J Immunol. 2001 Feb 1;166(3):1448-51
references.pmid: 11160182
references.citation: J Immunol. 2008 Sep 15;181(6):4332-9
references.pmid: 18768891
references.citation: J Leukoc Biol. 1999 Dec;66(6):915-22
references.pmid: 10614772
references.citation: Blood. 1990 Feb 1;75(3):531-45
references.pmid: 2137018
references.citation: Blood. 1999 Aug 15;94(4):1165-73
references.pmid: 10438703
references.citation: Prostaglandins Leukot Essent Fatty Acids. 2005 Sep-Oct;73(3-4):141-62
references.pmid: 16005201
references.citation: Gene. 1992 Sep 10;118(2):303-4
references.pmid: 1511907
references.citation: J Immunol. 2008 Aug 15;181(4):2813-20
references.pmid: 18684973
references.citation: J Immunol. 2004 Jun 1;172(11):7078-85
references.pmid: 15153530
references.citation: Arch Pharm Res. 2012 Jan;35(1):3-7
references.pmid: 22297737
references.citation: J Immunol. 2005 Jul 15;175(2):685-92
references.pmid: 16002663
references.citation: FEBS Lett. 2006 Oct 30;580(25):6022-6
references.pmid: 17046755
references.citation: ScientificWorldJournal. 2006 Oct 25;6:1375-84
references.pmid: 17072491
references.citation: Nat Biotechnol. 1998 Dec;16(13):1334-7
references.pmid: 9853614
references.citation: Biomed Pharmacother. 2007 Jun;61(5):261-7
references.pmid: 17418999
references.citation: Am J Physiol Lung Cell Mol Physiol. 2005 Nov;289(5):L842-8
references.pmid: 15964896
references.citation: Neuroscience. 2008 Oct 2;156(2):266-76
references.pmid: 18723082
references.citation: J Biol Chem. 2005 Mar 4;280(9):8031-40
references.pmid: 15576377
references.citation: Nat Med. 2006 Mar;12(3):330-4
references.pmid: 16415877
references.citation: Nat Med. 2002 Nov;8(11):1296-302
references.pmid: 12368905
references.citation: J Cell Sci. 2004 Jun 15;117(Pt 14):2909-16
references.pmid: 15173320
references.citation: Life Sci. 2005 Oct 28;77(24):3092-104
references.pmid: 16005025
references.citation: Biochem Biophys Res Commun. 2011 Jan 7;404(1):482-7
references.pmid: 21144840
references.citation: J Immunol. 2008 May 1;180(9):6211-21
references.pmid: 18424743
references.citation: J Cell Physiol. 2013 Feb;228(2):476-84
references.pmid: 22777765
references.citation: J Immunol. 2000 Mar 1;164(5):2660-6
references.pmid: 10679106
references.citation: Neurochem Res. 2008 Jan;33(1):125-33
references.pmid: 17703360
references.citation: J Clin Invest. 1993 Jul;92(1):75-82
references.pmid: 8326019
references.citation: J Immunol. 2012 Sep 1;189(5):2597-605
references.pmid: 22844113
references.citation: Mol Pharmacol. 2006 Jul;70(1):241-8
references.pmid: 16569709
references.citation: Int Arch Allergy Immunol. 2005;137 Suppl 1:21-6
references.pmid: 15947481
references.citation: J Immunol. 2006 Dec 1;177(11):8017-26
references.pmid: 17114475
references.citation: Biochem Pharmacol. 2006 May 14;71(10):1488-96
references.pmid: 16549058
references.citation: Life Sci. 1999;65(17):1845-56
references.pmid: 10576564
references.citation: Clin Immunol. 2000 Sep;96(3):236-42
references.pmid: 10964542
references.citation: J Pharmacol Exp Ther. 2009 Feb;328(2):426-34
references.pmid: 19023040
references.citation: Mol Pharmacol. 2004 Nov;66(5):1213-22
references.pmid: 15308762
references.citation: Pharmacol Rev. 2006 Sep;58(3):463-87
references.pmid: 16968948
references.citation: Mol Pharmacol. 2008 Aug;74(2):392-402
references.pmid: 18458054
references.citation: J Biol Chem. 2005 Apr 29;280(17):17449-57
references.pmid: 15728176
references.citation: J Neurosci. 2001 Jan 15;21(2):RC123
references.pmid: 11160457
references.citation: J Immunol. 2006 Mar 1;176(5):3044-52
references.pmid: 16493063
references.citation: J Immunol. 2009 Nov 15;183(10):6569-78
references.pmid: 19846866
references.citation: Biochem Biophys Res Commun. 2004 Nov 5;324(1):458-65
references.pmid: 15465041
references.citation: Mol Pharmacol. 2011 Jan;79(1):77-90
references.pmid: 20943772
references.citation: J Biol Chem. 2010 May 7;285(19):14338-45
references.pmid: 20220135
references.citation: J Immunol. 2007 Jun 1;178(11):7395-404
references.pmid: 17513790
references.citation: Biochem Biophys Res Commun. 2000 May 27;272(1):276-83
references.pmid: 10872839
references.citation: Exp Mol Med. 2010 Apr 30;42(4):302-9
references.pmid: 20177146
references.citation: J Biol Chem. 1999 Mar 5;274(10):6027-30
references.pmid: 10037679
references.citation: Regul Pept. 2006 Nov 15;137(1-2):67-74
references.pmid: 16949684
references.citation: Am J Physiol Cell Physiol. 2012 May 1;302(9):C1331-45
references.pmid: 22237406
references.citation: Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1359-64
references.pmid: 11818541
references.citation: Biochem Pharmacol. 2006 Sep 28;72(7):860-8
references.pmid: 16859643
references.citation: J Biol Chem. 2001 Jun 29;276(26):23645-52
references.pmid: 11316806
references.citation: Int J Immunopathol Pharmacol. 2004 May-Aug;17(2):145-56
references.pmid: 15171815
references.citation: J Neurosci. 2001 Dec 1;21(23):9235-45
references.pmid: 11717357